title: Warfarin for nonvalvular atrial fibrillation in primary care--another example of the age paradox?
authors.affiliation: Sanquhar Health Centre, UK. chrisburton@medicine21.com
authors.forename: C D
authors.initials: CD
authors.lastname: Burton
authors.forename: K E
authors.initials: KE
authors.lastname: Hamilton
authors.forename: C G
authors.initials: CG
authors.lastname: Isles
authors.forename: J
authors.initials: J
authors.lastname: Norrie
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000209:etiology / Q000517:prevention & control; D000075202:Contraindications; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011320:Primary Health Care; D012606:Scotland / Q000453:epidemiology; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin